Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.21 -0.02 (-0.91%)
As of: Sep 29, 2026 · 3:40 PM EDT

Xtl Biopharmaceuticals (XTLB) Gross Margin (2011 - 2024)

Updated

Xtl Biopharmaceuticals (XTLB) posted Gross Margin of -14.88% for the quarter ended Dec 31, 2024.

Analysis

Xtl Biopharmaceuticals (XTLB) Gross Margin (2011 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Xtl Biopharmaceuticals' Gross Margin came in at 0.67%.

  • The figure for the quarter ended Dec 31, 2024 stands as the highest quarterly Gross Margin in data going back to the quarter ended Jun 30, 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 68.19%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 74.74%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 73.54%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 78.02%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 83.60%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 72.04%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 79.76%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 85.33%
10 Xtl Biopharmaceuticals 2.11 Bn 2.11 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -14.88%
Sep 30, 2014 57.84%
Jun 30, 2014 70.26%
Mar 31, 2014 73.25%
Dec 31, 2013 75.53%
Sep 30, 2013 61.95%
Jun 30, 2013 63.28%
Mar 31, 2013 70.43%
Dec 31, 2012 62.35%
Sep 30, 2012 54.52%
Jun 30, 2012 64.04%
Mar 31, 2012 61.24%
Dec 31, 2011 78.47%
Sep 30, 2011 67.86%
Jun 30, 2011 68.16%
API Access

Xtl Biopharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=XTLB&period=max&api_key=YOUR_API_KEY